High Resolution Crystal Structure of the Grb2 SH2 Domain with a Phosphopeptide Derived from CD28

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Higo, Kunitake ^a   Ikura, Teikichi ^b   Oda, Masayuki ^c   Morii, Hisayuki ^d   Takahashi, Jun ^a   Abe, Ryo ^a   Ito, Nobutoshi ^b  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; PHOSPHOPEPTIDE; PROLINE; PROTEIN SH2;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; HUMAN; MOLECULAR MODEL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN;

ANTIGENS, CD28; CRYSTALLOGRAPHY; GRB2 ADAPTOR PROTEIN; MODELS, MOLECULAR; PHOSPHOPEPTIDES; PROTEIN CONFORMATION; SRC HOMOLOGY DOMAINS;

EID: 84884753653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074482     Document Type: Article

References (23)

1. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, et al. (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 431-442.
2. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, et al. (1992) Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360: 689-692.
3. McNemar C, Snow ME, Windsor WT, Prongay A, Mui P, et al. (1997) Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2. Biochemistry 36: 10006-10014.
4. Ogura K, Tsuchiya S, Terasawa H, Yuzawa S, Hatanaka H, et al. (1999) Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide. J Mol Biol 289: 439-445.
5. Rahuel J, Gay B, Erdmann D, Strauss A, Garcia-Echeverria C, et al. (1996) Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode. Nat Struct Biol 3: 586-589.
6. Thornton KH, Mueller WT, McConnell P, Zhu G, Saltiel AR, et al. (1996) Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain. Biochemistry 35: 11852-11864.
7. Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, et al. (2002) Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. J Mol Biol 315: 1167-1177.
8. Mueller DL, Jenkins MK, Schwartz RH, (1989) Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7: 445-480.
9. Schneider H, Cai YC, Prasad KV, Shoelson SE, Rudd CE, (1995) T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras. Eur J Immunol 25: 1044-1050.
10. Rudd CE, Schneider H, (2003) Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol 3: 544-556.
11. Rudolph R, Lilie H, (1996) In vitro folding of inclusion body proteins. FASEB J 10: 49-56.
12. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, et al. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67: 235-242.
13. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.
14. Benfield AP, Teresk MG, Plake HR, DeLorbe JE, Millspaugh LE, et al. (2006) Ligand preorganization may be accompanied by entropic penalties in protein-ligand interactions. Angew Chem Int Ed Engl 118: 6984-6989.
15. Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, et al. (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67: 355-367.
16. Emsley P, Lohkamp B, Scott WG, Cowtan K, (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501.
17. Kraulis PJ, (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24: 946-950.
18. DeLorbe JE, Clements JH, Whiddon BB, Martin SF, (2010) Thermodynamic and structural effects of macrocyclic constraints in protein-ligand interactions. ACS Med Chem Lett 1: 448-452.
19. Ettmayer P, France D, Gounarides J, Jarosinski M, Martin MS, et al. (1999) Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2. J Med Chem 42: 971-980.
20. Das S, Raychaudhuri M, Sen U, Mukhopadhyay D, (2011) Functional implications of the conformational switch in AICD peptide upon binding to Grb2-SH2 domain. J Mol Biol 414: 217-230.
21. Suga M, Inubushi C, Okabe N, (1998) O-Phospo-L-tyrosine. Acta Cryst C54: 83-85.
22. Rahuel J, Garcia-Echeverria C, Furet P, Strauss A, Caravatti G, et al. (1998) Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands. J Mol Biol 279: 1013-1022.
23. Nolte RT, Eck MJ, Schlessinger J, Shoelson SE, Harrison SC, (1996) Crystal structure of the PI3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nat Struct Biol 3: 364-374.